Targeting nascent soluble Aβ42 for potential Alzheimer drug development

Authors

  • Mingming Zhang,

    1. Townsend Family Laboratories, Department of Psychiatry and Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia, Vancouver, BC, Canada
    Search for more papers by this author
  • Laura Hausmann,

    1. Department of Neurology, RWTH Aachen, Medical School, Aachen, Germany
    Search for more papers by this author
  • Weihong Song

    Corresponding author
    • Townsend Family Laboratories, Department of Psychiatry and Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia, Vancouver, BC, Canada
    Search for more papers by this author

Address correspondence and reprint requests to Weihong Song, Townsend Family Laboratories, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T1Z3, Canada. E-mail: weihong@mail.ubc.ca

Abstract

Read the full article ‘Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Ab42 without affecting other Ab pools’ on doi: 10.1111/jnc.12125.

Ancillary